Peter Christian Warnke to Combined Modality Therapy
This is a "connection" page, showing publications Peter Christian Warnke has written about Combined Modality Therapy.
Connection Strength
0.233
-
A 31-year-old woman with a transformed low-grade glioma. JAMA. 2010 Mar 10; 303(10):967-76.
Score: 0.065
-
Low grade astrocytoma of the pituitary stalk. Acta Neurochir (Wien). 2007 Mar; 149(3):307-11; discussion 311-2.
Score: 0.053
-
Response to Drs. Simpson, et al.: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys. 1994 Apr 30; 29(1):220.
Score: 0.022
-
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. Lancet Oncol. 2013 Aug; 14(9):823-33.
Score: 0.021
-
Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. J Neurol Neurosurg Psychiatry. 2013 Dec; 84(12):1384-91.
Score: 0.020
-
Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg. 1993 May; 78(5):762-6.
Score: 0.020
-
[Stereotactic interstitial radiosurgery and percutaneous radiotherapy in treatment of cerebral metastases]. Nervenarzt. 1993 Feb; 64(2):108-13.
Score: 0.020
-
Low grade supratentorial astrocytomas: management and prognostic factors. Cancer. 1994 Dec 15; 74(12):3247-8.
Score: 0.006
-
Long-term follow-up results of 175 patients with malignant glioma. Acta Neurochir (Wien). 1994; 131(1-2):164-6.
Score: 0.005